Jeff Weinstein

McDermott Will & Emery

Contact
View Bio
RSS

Latest Posts › Healthcare Reform

Share:

FDA Relaxes Critical Positions on Use of Scientific Information in Off-Label Communications

On January 6, 2025, the US Food and Drug Administration (FDA) published final guidance titled “Communications From Firms to Health Care Providers Regarding Scientific Information on Unapproved Uses of Approved/Cleared Medical...more

2/18/2025  /  Department of Health and Human Services (HHS) , Enforcement Actions , Final Rules , Food and Drug Administration (FDA) , Health Care Providers , Healthcare Reform , Medical Devices , Pharmaceutical Industry , Prescription Drugs , Regulatory Requirements

End of an Era: FDA Retires 2017 Interim Policies for Bulk Drug Lists

On January 7, 2025, the US Food and Drug Administration (FDA) issued two parallel guidance documents for the Section 503A and Section 503B bulk drug lists, announcing the end of FDA’s 2017 interim policies. Under the new...more

2/4/2025  /  Final Rules , Food and Drug Administration (FDA) , Healthcare , Healthcare Reform , Life Sciences , New Guidance , Pharmaceutical Industry , Prescription Drugs , Regulatory Agenda , Regulatory Requirements
2 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide